NCT06203002

Brief Summary

Evaluation of the efficacy of LX9211 compared to placebo in reducing DPNP. Please see study website: https://diabeticpainstudy.com/

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
496

participants targeted

Target at P75+ for phase_2

Timeline
Completed

Started Nov 2023

Shorter than P25 for phase_2

Geographic Reach
1 country

108 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 29, 2023

Completed
1 day until next milestone

First Submitted

Initial submission to the registry

November 30, 2023

Completed
1 month until next milestone

First Posted

Study publicly available on registry

January 12, 2024

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 14, 2025

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

February 24, 2025

Completed
Last Updated

October 10, 2025

Status Verified

October 1, 2025

Enrollment Period

1.1 years

First QC Date

November 30, 2023

Last Update Submit

October 8, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change from Baseline to Week 8 in Average Daily Pain Score (ADPS)

    ADPS is based on the 11-point numerical rating scale (NRS) \[0 (no pain) to 10 (worst imaginable pain)\].

    Baseline, Week 8

Secondary Outcomes (4)

  • Change from Baseline to Week 8 in Burning Pain

    Baseline, Week 8

  • Change from Baseline to Week 8 in Pain Interference on Sleep

    Baseline, Week 8

  • Patient Global Impression of Change (PGIC) Score at Week 8

    Week 8

  • Change from Baseline to Week 8 in Total Neuropathic Pain Symptom Inventory (NPSI) Score

    Baseline, Week 8

Study Arms (4)

LX9211 Low Dose

EXPERIMENTAL

LX9211 low dose, orally, once daily during a blinded treatment period.

Drug: LX9211 (blinded)

LX9211 High Dose

EXPERIMENTAL

LX9211 high dose, orally, once daily during a blinded treatment period.

Drug: LX9211 (blinded)

LX9211 High Dose Followed by Low Dose

EXPERIMENTAL

LX9211 high dose followed by LX9211 low dose, orally, once daily during a blinded treatment period.

Drug: LX9211 (blinded)

LX9211 Placebo

PLACEBO COMPARATOR

LX9211 matching placebo, orally, once daily during a blinded treatment period.

Drug: Placebo (blinded)

Interventions

LX9211 matching placebo tablets

LX9211 Placebo

LX9211 (blinded) tablets

LX9211 High DoseLX9211 High Dose Followed by Low DoseLX9211 Low Dose

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Participant has given written informed consent to participate in the study in accordance with local regulations
  • Adult male and female participants ≥18 years of age at the Screening Visit
  • Body mass index ≥18.0 to ≤40.0 kilogram per meter square (kg/m\^2) at Screening
  • Diagnosis of type 1 diabetes mellitus (T1DM) or type 2 diabetes mellitus (T2DM) with chronic DPNP, at Screening
  • Pain from DPNP present for at least 6 months prior to Screening
  • At the Screening Visit, glycosylated hemoglobin (A1C) must be ≤11%.
  • Stable regimen for the treatment of T1DM or T2DM for ≥3 months prior to Screening
  • Willing to adhere to the prohibitions and restrictions specified in the protocol.

You may not qualify if:

  • Presence of other painful conditions that may confound assessment or self-evaluation of DPNP
  • History of neurolytic or neurosurgical therapy for DPNP
  • Use of opioid medications for management of DPNP within the 2 months prior to the Screening Visit.
  • Use of prescription topical analgesics (eg, capsaicin) indicated for neuropathic pain within 3 months prior to Screening
  • Use of nonsteroidal anti-inflammatory drugs (NSAIDs) less than 2 weeks prior to Screening

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (108)

Lexicon Investigational Site (128)

Anniston, Alabama, 36207, United States

Location

Lexicon Investigational Site (222)

Birmingham, Alabama, 35216, United States

Location

Lexicon Investigational Site (189)

Daphne, Alabama, 36526, United States

Location

Lexicon Investigational Site (215)

Guntersville, Alabama, 35976, United States

Location

Lexicon Investigational Site (115)

Chandler, Arizona, 85286, United States

Location

Lexicon Investigational Site (195)

Phoenix, Arizona, 85028, United States

Location

Lexicon Investigational Site (206)

Scottsdale, Arizona, 85258, United States

Location

Lexicon Investigational Site (102)

Tucson, Arizona, 85741, United States

Location

Lexicon Investigational Site (107)

Anaheim, California, 92801, United States

Location

Lexicon Investigational Site (173)

Canoga Park, California, 91303, United States

Location

Lexicon Investigational Site (179)

Escondido, California, 92025, United States

Location

Lexicon Investigational Site (161)

Fresno, California, 93710, United States

Location

Lexicon Investigational Site (112)

Greenbrae, California, 94904, United States

Location

Lexicon Investigational Site (204)

Huntington Beach, California, 92647, United States

Location

Lexicon Investigational Site (191)

Inglewood, California, 90301, United States

Location

Lexicon Investigational Site (163)

Lomita, California, 90717, United States

Location

Lexicon Investigational Site (169)

Long Beach, California, 90806, United States

Location

Lexicon Investigational Site (111)

Sacramento, California, 95821, United States

Location

Lexicon Investigational Site (126)

Sacramento, California, 95821, United States

Location

Lexicon Investigational Site (129)

San Diego, California, 92103, United States

Location

Lexicon Investigational Site (154)

San Diego, California, 92120, United States

Location

Lexicon Investigational Site (124)

Tustin, California, 92780, United States

Location

Lexicon Investigational Site (211)

Vista, California, 92081, United States

Location

Lexicon Investigational Site (171)

Walnut Creek, California, 94596, United States

Location

Lexicon Investigational Site (181)

Walnut Creek, California, 94598, United States

Location

Lexicon Investigational Site (119)

Brandon, Florida, 33511, United States

Location

Lexicon Investigational Site (194)

Brandon, Florida, 33511, United States

Location

Lexicon Investigational Site (177)

Daytona Beach, Florida, 32117, United States

Location

Lexicon Investigational Site (198)

Fleming Island, Florida, 32003, United States

Location

Lexicon Investigational Site (109)

Fort Myers, Florida, 33912, United States

Location

Lexicon Investigational Site (180)

Hollywood, Florida, 33024, United States

Location

Lexicon Investigational Site (188)

Jacksonville, Florida, 32256, United States

Location

Lexicon Investigational Site (164)

Miami, Florida, 33176, United States

Location

Lexicon Investigational Site (105)

New Port Richey, Florida, 34652, United States

Location

Lexicon Investigational Site (146)

Orlando, Florida, 32801, United States

Location

Lexicon Investigational Site (144)

Orlando, Florida, 32806, United States

Location

Lexicon Investigational Site (123)

Ormond Beach, Florida, 32174, United States

Location

Lexicon Investigational Site (182)

Plantation, Florida, 33317, United States

Location

Lexicon Investigational Site (133)

The Villages, Florida, 32159, United States

Location

Lexicon Investigational Site (138)

The Villages, Florida, 32162, United States

Location

Lexicon Investigational Site (131)

Winter Haven, Florida, 33880, United States

Location

Lexicon Investigational Site (103)

Winter Park, Florida, 32789, United States

Location

Lexicon Investigational Site (150)

Atlanta, Georgia, 30303, United States

Location

Lexicon Investigational Site (151)

Marietta, Georgia, 30060, United States

Location

Lexicon Investigational Site (172)

Chicago, Illinois, 60623, United States

Location

Lexicon Investigational Site (132)

Flossmoor, Illinois, 60422, United States

Location

Lexicon Investigational Site (185)

El Dorado, Kansas, 67042, United States

Location

Lexicon Investigational Site (178)

Newton, Kansas, 67114, United States

Location

Lexicon Investigational Site (186)

Wichita, Kansas, 67207, United States

Location

Lexicon Investigational Site (213)

Owensboro, Kentucky, 42303, United States

Location

Lexicon Investigational Site (170)

New Orleans, Louisiana, 70115, United States

Location

Lexicon Investigational Site (190)

New Orleans, Louisiana, 70119, United States

Location

Lexicon Investigational Site (121)

Boston, Massachusetts, 02115, United States

Location

Lexicon Investigational Site (140)

New Bedford, Massachusetts, 02740, United States

Location

Lexicon Investigational Site (225)

Waltham, Massachusetts, 02451, United States

Location

Lexicon Investigational Site (125)

Ann Arbor, Michigan, 48109, United States

Location

Lexicon Investigational Site (108)

Dearborn, Michigan, 48126, United States

Location

Lexicon Investigational Site (139)

Olive Branch, Mississippi, 38654, United States

Location

Lexicon Investigational Site (104)

Hazelwood, Missouri, 63042, United States

Location

Lexicon Investigational Site (174)

Kansas City, Missouri, 64114, United States

Location

Lexicon Investigational Site (184)

Springfield, Missouri, 65807, United States

Location

Lexicon Investigational Site (156)

St Louis, Missouri, 63110, United States

Location

Lexicon Investigational Site (116)

Papillion, Nebraska, 68046, United States

Location

Lexicon Investigational Site (216)

Las Vegas, Nevada, 89106, United States

Location

Lexicon Investigational Site (162)

Las Vegas, Nevada, 89123, United States

Location

Lexicon Investigational Site (142)

New York, New York, 100029, United States

Location

Lexicon Investigational Site (227)

Rochester, New York, 14609, United States

Location

Lexicon Investigational Site (167)

Schenectady, New York, 12304, United States

Location

Lexicon Investigational Site (122)

Westfield, New York, 14787, United States

Location

Lexicon Investigational Site (110)

Williamsville, New York, 14221, United States

Location

Lexicon Investigational Site (200)

Asheville, North Carolina, 28803, United States

Location

Lexicon Investigational Site (209)

Greensboro, North Carolina, 27410, United States

Location

Lexicon Investigational Site (212)

Monroe, North Carolina, 28112, United States

Location

Lexicon Investigational Site (106)

Morehead City, North Carolina, 28557, United States

Location

Lexicon Investigational Site (145)

Winston-Salem, North Carolina, 27103, United States

Location

Lexicon Investigational Site (220)

Beavercreek, Ohio, 45432, United States

Location

Lexicon Investigational Site (168)

Dayton, Ohio, 45424, United States

Location

Lexicon Investigational Site (148)

Norman, Oklahoma, 73069, United States

Location

Lexicon Investigational Site (210)

Oklahoma City, Oklahoma, 73102, United States

Location

Lexicon Investigational Site (187)

Eugene, Oregon, 97404, United States

Location

Lexicon Investigational Site (183)

Charleston, South Carolina, 29406, United States

Location

Lexicon Investigational Site (201)

Columbia, South Carolina, 29205, United States

Location

Lexicon Investigational Site (113)

Greenville, South Carolina, 29607, United States

Location

Lexicon Investigational Site (205)

North Charleston, South Carolina, 29405, United States

Location

Lexicon Investigational Site (202)

Rock Hill, South Carolina, 29730, United States

Location

Lexicon Investigational Site (157)

Summerville, South Carolina, 29486, United States

Location

Lexicon Investigational Site (160)

Memphis, Tennessee, 38119, United States

Location

Lexicon Investigational Site (192)

Austin, Texas, 78759, United States

Location

Lexicon Investigational Site (199)

Baytown, Texas, 77521, United States

Location

Lexicon Investigational Site (193)

Dallas, Texas, 75230, United States

Location

Lexicon Investigational Site (158)

Dallas, Texas, 75231, United States

Location

Lexicon Investigational Site (153)

Euless, Texas, 76040, United States

Location

Lexicon Investigational Site (114)

Flower Mound, Texas, 75028, United States

Location

Lexicon Investigational Site (196)

Harlingen, Texas, 78550, United States

Location

Lexicon Investigational Site (120)

Houston, Texas, 77030, United States

Location

Lexicon Investigational Site (197)

Houston, Texas, 77065, United States

Location

Lexicon Investigational Site (152)

Houston, Texas, 77074, United States

Location

Lexicon Investigational Site (214)

Katy, Texas, 77494, United States

Location

Lexicon Investigational Site (155)

Lewisville, Texas, 75057, United States

Location

Lexicon Investigational Site (223)

Mesquite, Texas, 75150, United States

Location

Lexicon Investigational Site (203)

San Antonio, Texas, 78229, United States

Location

Lexicon Investigational Site (159)

San Antonio, Texas, 78233, United States

Location

Lexicon Investigational Site (221)

San Antonio, Texas, 78240, United States

Location

Lexicon Investigational Site (101)

Salt Lake City, Utah, 84102, United States

Location

Lexicon Investigational Site (219)

Salt Lake City, Utah, 84107, United States

Location

Lexicon Investigational Site (224)

St. George, Utah, 84790, United States

Location

Lexicon Investigational Site (130)

Manassas, Virginia, 20110, United States

Location

Lexicon Investigational Site (165)

Norfolk, Virginia, 23510, United States

Location

Study Design

Study Type
interventional
Phase
phase 2
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 30, 2023

First Posted

January 12, 2024

Study Start

November 29, 2023

Primary Completion

January 14, 2025

Study Completion

February 24, 2025

Last Updated

October 10, 2025

Record last verified: 2025-10

Data Sharing

IPD Sharing
Will not share

Locations